Ticker Symbol: ACGN

Aceragen Inc

Exchange: NASDAQ Country: US Currency: USD Asset Type: Common Stock CIK:0000861838

Company Profile

idera pharmaceuticals is a clinical stage biotechnology company with expertise in discovering, developing and commercializing novel nucleic acid therapeutics to treat patients with serious and life-threatening diseases. idera is focused on harnessing the potential of our proprietary technology to treat genetically defined forms of b-cell lymphomas and rare autoimmune diseases.

Sector: Manufacturing

Industry: Biological Product (except Diagnostic) Manufacturing

Standard Industrial Classification Code (SIC code): 2836

Address: 505 Eagleview Blvd Ste 212

Website: http://www.iderapharma.com/

CEO: Vincent Milano

Tags: N/A

Pricing

Last Updated: December 31, 1969 07:00 PM EST

Previous Close: -

Change: - ( 0.00%)

Days Range: $0.38 - $0.38

Beta: -

52wk. High: -

52wk. Low: -

Ytd. Change 0.00%

50 Day Moving Average: -

200 Day Moving Average: -

Shares Outstanding: 8423504

Valuation

Market Cap: 320.1M

PE Ratio: -0.14

EPS (TTM): -2.67

Dividends

Dividend Per Share (TTM): -

Dividend Yield (TTM): 0.00%

Ex-Dividend Date: N/A